| 673 |
increased |
signaling
(GO:0023052)
|
TGF-beta
(PR:000000046)
|
1283: Activation, TGF-beta pathway
|
| 40 |
increased |
excretion
(GO:0007588)
|
Tetrahydroaldosterone-3-glucuronide
(CHEBI:88728)
|
401: Increase, Biliary excretion TH glucuronide
|
| 265 |
decreased |
hormone biosynthetic process
(GO:0042446)
|
testosterone
(CHEBI:17347)
|
2 Events
|
| 1028 |
increased |
testosterone biosynthetic process
(GO:0061370)
|
testosterone
(CHEBI:17347)
|
2272: Testosterone levels, increased
|
| 93 |
decreased |
testosterone biosynthetic process
(GO:0061370)
|
testosterone
(CHEBI:17347)
|
5 Events
|
| 94 |
decreased |
|
testosterone
(CHEBI:17347)
|
2 Events
|
| 389 |
decreased |
receptor binding
(GO:0005102)
|
testosterone
(CHEBI:17347)
|
743: Decreased, Testosterone binding to androgen receptor (hypothalamus)
|
| 723 |
increased |
Testicular atrophy
(HP:0000029)
|
Testis
(FMA:7210)
|
1506: Testicular atrophy
|
| 704 |
decreased |
testicular atrophy
(MP:0003205)
|
Testis
(FMA:7210)
|
None
|
| 963 |
increased |
Abnormality of the testis
(HP:0000035)
|
Testis
(FMA:7210)
|
2206: Increased, histomorphological alteration of testis
|
| 728 |
increased |
gene expression
(GO:0010467)
|
teratocarcinoma-derived growth factor 1
(PR:000030513)
|
None
|
| 1054 |
occurrence |
T cell migration
(GO:0072678)
|
T cell
(CL:0000084)
|
2275: Gluten reactive adaptive T-cells with antigen presenting cells, co-localization
|
| 903 |
decreased |
T cell activation involved in immune response
(GO:0002286)
|
T cell
(CL:0000084)
|
1702: Suppression of T cell activation
|
| 203 |
increased |
T cell activation
(GO:0042110)
|
T cell
(CL:0000084)
|
272: Activation/Proliferation, T-cells
|
| 1041 |
increased |
T cell activation involved in immune response
(GO:0002286)
|
T cell
(CL:0000084)
|
None
|
| 1042 |
increased |
T cell migration
(GO:0072678)
|
T cell
(CL:0000084)
|
None
|
| 1057 |
occurrence |
T cell activation involved in immune response
(GO:0002286)
|
T cell
(CL:0000084)
|
2260: Gluten-reactive CD4+ T cells, activation
|
| 62 |
decreased |
synapse assembly
(GO:0007416)
|
synapse
(GO:0045202)
|
385: Decrease of synaptogenesis
|
| 984 |
disrupted |
|
synapse
(GO:0045202)
|
2005: Altered neurotransmission in development
|
| 708 |
abnormal |
chemical synaptic transmission
(GO:0007268)
|
synapse
(GO:0045202)
|
758: Hippocampal Physiology, Altered
|
| 1075 |
increased |
serotonin receptor activity
(GO:0099589)
|
Surface of brain
(FMA:86594)
|
2308: Increased, stimulation of brain serotonin 5-HT1a, 5-HT2c receptors
|
| 919 |
increased |
respiratory electron transport chain
(GO:0022904)
|
superoxide
(CHEBI:18421)
|
2120: Superoxide generation, increased
|
| 917 |
decreased |
FAD metabolic process
(GO:0046443)
|
succinate dehydrogenase complex
(GO:0045281)
|
2118: Succinate dehydrogenase, inhibited
|
| 918 |
decreased |
succinate metabolic process
(GO:0006105)
|
succinate dehydrogenase complex
(GO:0045281)
|
2118: Succinate dehydrogenase, inhibited
|
| 617 |
increased |
neuropeptide hormone activity
(GO:0005184)
|
Substance P
(CHEBI:80308)
|
1222: SP (Substance P) release, Local increase of SP
|